Clinical Trials : Colitis, Ulcerative

Completed

Nombre del estudio: Pharmacokinetics/Pharmacodynamics Biomarker Study in Active Ulcerative Colitis Patients
Condición: Colitis, Ulcerative
Fecha: 2011-01-25
Intervenciones:

Biological: Anrukinzumab 200 m

Active, not recruiting

Nombre del estudio: A Study to Assess the Safety and Pharmacokinetics of Subcutaneously Administered Golimumab, a Human Anti-TNFα Antibody, in Pediatric Patients With Moderate to Severe Active Ulcerative Colitis
Condición: Colitis, Ulcerative
Fecha: 2013-07-12
Intervenciones: Drug: Golimumab Golimumab will be administered subcutaneously. For participants weighing less than 45 kg

Completed

Nombre del estudio: The Efficacy and Safety of Kappaproct in Chronic Active Treatment Refractory Ulcerative Colitis Patients
Condición: Colitis, Ulcerative
Fecha: 2011-12-12
Intervenciones:

Drug: Kappaproct 30 mg rectal

Completed

Nombre del estudio: GSK2982772 Study in Ulcerative Colitis Patients
Condición: Colitis, Ulcerative
Fecha: 2016-09-13
Intervenciones:

Drug: GSK2982772 GSK2982772 is

Completed

Nombre del estudio: A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis
Condición: Colitis, Ulcerative
Fecha: 2025-11-04
Intervenciones: JNJ-77242113 tablet will be administered orally.

COMPLETED

Nombre del estudio: A Study of Vedolizumab in Adults in Real-World Practice
Condición: Colitis, Ulcerative
Fecha: 2025-11-04

COMPLETED

Nombre del estudio: COlonic Salvage by Therapeutic Appendectomy.
Condición: Colitis, Ulcerative
Fecha: 2025-11-04
Intervenciones: Surgery will be performed under general anaesthesia.The laparoscopic appendectomy can be performed with the use of 3 trocars; one subumbilical,

COMPLETED

Nombre del estudio: A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis (UC)
Condición: Colitis, Ulcerative
Fecha: 2025-11-04
Intervenciones: As per BSA and body weight Ustekinumab will be administered SC and IV.

COMPLETED

Nombre del estudio: A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Ulcerative Colitis (UC)
Condición: Colitis, Ulcerative
Fecha: 2025-11-04
Intervenciones: Vedolizumab IV infusion.

COMPLETED

Nombre del estudio: To Evaluate Efficacy and Long-term Safety of Ozanimod in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis
Condición: Colitis, Ulcerative
Fecha: 2025-11-04
Intervenciones: Ozanimod is an orally bioavailable, small molecule compound that activates the sphingosine 1-phosphate 1 receptor (S1P1) and the S1P 5 receptor (S1P5)

Buscar resultados de ensayos clínicos

Colitis, Ulcerative - 30 Studies Found

Estado	Estudiar
Completed	Nombre del estudio: Pharmacokinetics/Pharmacodynamics Biomarker Study in Active Ulcerative Colitis Patients Condición: Colitis, Ulcerative Fecha: 2011-01-25 Intervenciones: Biological: Anrukinzumab 200 m
Active, not recruiting	Nombre del estudio: A Study to Assess the Safety and Pharmacokinetics of Subcutaneously Administered Golimumab, a Human Anti-TNFα Antibody, in Pediatric Patients With Moderate to Severe Active Ulcerative Colitis Condición: Colitis, Ulcerative Fecha: 2013-07-12 Intervenciones: Drug: Golimumab Golimumab will be administered subcutaneously. For participants weighing less than 45 kg
Completed	Nombre del estudio: The Efficacy and Safety of Kappaproct in Chronic Active Treatment Refractory Ulcerative Colitis Patients Condición: Colitis, Ulcerative Fecha: 2011-12-12 Intervenciones: Drug: Kappaproct 30 mg rectal
Completed	Nombre del estudio: GSK2982772 Study in Ulcerative Colitis Patients Condición: Colitis, Ulcerative Fecha: 2016-09-13 Intervenciones: Drug: GSK2982772 GSK2982772 is
Completed	Nombre del estudio: A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis Condición: Colitis, Ulcerative Fecha: 2025-11-04 Intervenciones: JNJ-77242113 tablet will be administered orally.
COMPLETED	Nombre del estudio: A Study of Vedolizumab in Adults in Real-World Practice Condición: Colitis, Ulcerative Fecha: 2025-11-04
COMPLETED	Nombre del estudio: COlonic Salvage by Therapeutic Appendectomy. Condición: Colitis, Ulcerative Fecha: 2025-11-04 Intervenciones: Surgery will be performed under general anaesthesia.The laparoscopic appendectomy can be performed with the use of 3 trocars; one subumbilical,
COMPLETED	Nombre del estudio: A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis (UC) Condición: Colitis, Ulcerative Fecha: 2025-11-04 Intervenciones: As per BSA and body weight Ustekinumab will be administered SC and IV.
COMPLETED	Nombre del estudio: A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Ulcerative Colitis (UC) Condición: Colitis, Ulcerative Fecha: 2025-11-04 Intervenciones: Vedolizumab IV infusion.
COMPLETED	Nombre del estudio: To Evaluate Efficacy and Long-term Safety of Ozanimod in Japanese Subjects With Moderately to Severely Active Ulcerative Colitis Condición: Colitis, Ulcerative Fecha: 2025-11-04 Intervenciones: Ozanimod is an orally bioavailable, small molecule compound that activates the sphingosine 1-phosphate 1 receptor (S1P1) and the S1P 5 receptor (S1P5)